Johnson & Johnson To Stop Selling Opioids In US Under $230 Million Settlement

Sunday, 27 June 2021Newsdesk

Johnson & Johnson, one of the pharmaceutical giants accused of fueling the deadly opioid crisis in the United States, will stop making or selling the drugs in the US under a $230 million settlement with New York state.

New Delhi, 27 June 2021

As per news report of NDTV,The agreement allows Johnson & Johnson to resolve litigation over its role in the epidemic, which has killed more than half a million people since 1999, according to a statement from New York attorney general Letitia James. For its part, J&J announced in a separate statement that the settlement allowed it to avoid a trial that was scheduled to begin Monday. The settlement "is not an admission of liability or wrongdoing by the company," it said, noting that other nationwide legal proceedings are underway, including a trial in California.

Source -NDTV